uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Silodyx
Authorised
Human
Details
EMA number
EMEA/H/C/001209
ATC code
G04CA04
Authorisation
29 January 2010
Revision
17
EMA page
Therapeutic indication
Treatment of the signs and symptoms of benign prostatic hyperplasia (BPH)
MeSH:
Prostatic Hyperplasia
Group:
Urologicals
Active substances
silodosin
Marketing Authorisation Holder
Recordati Ireland Ltd
MAH
Timeline
Filter by authority:
EMA
Silodyx authorised
29 Jan 2010
authorised
regulatory
Silodyx | uMedical